Overview
GOVX market data
Price History
GOVX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$22.40 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.75 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.81 – $22.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $4.6 · P/B 1.34 · P/S 0.75.
Company news
8-K filing — GeoVax Labs, Inc. (GOVX)SEC EDGAR · Jul 10, 2026, 8:04 PM
'White House Adds Pandemic Response Staff as Ebola Cases Rise' - Bloomberg NewsBenzinga · Jul 1, 2026, 4:25 PM
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains LowBenzinga · Jun 26, 2026, 5:15 PM
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response EffortsBenzinga · Jun 5, 2026, 6:30 PM
Is Co-Diagnostics National Security’s Next Diagnostic Pick?Investing.com · May 28, 2026, 5:15 PM
Why Estee Lauder Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketBenzinga · May 22, 2026, 1:05 PM
WHO Chief Tedros Says There Are Currently Almost 750 Suspected Ebola Cases And 177 Suspected Ebola DeathsBenzinga · May 22, 2026, 11:15 AM
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola ThreatsBenzinga · May 20, 2026, 7:15 PM
GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms; Company Highlights Potential Role of MVA-Based Vaccine Technologies in Addressing Emerging Hemorrhagic Fever Threats, Including Ebola and Marburg VirusesBenzinga · May 20, 2026, 2:20 PM
Why Is GeoVax Labs Stock Falling Tuesday?Benzinga · May 19, 2026, 1:35 PM